INSIGHTS ON CLINICAL TRIAL DESIGN
-
Investigator Perspectives On What Matters In Obesity And GLP-1 Studies
Retention, body composition, maintenance therapy, amylin combinations, and behavioral support are reshaping obesity trials. Learn how sponsors can reduce dropout risk and strengthen clinical data.
-
BCVA, OCT, And IOP Testing In Clinical Trials
Are minor inconsistencies in room setup and technician technique quietly compromising your study data? Learn how closing small operational gaps can prevent major downstream risks.
-
What Clinical Trial Management Solutions Don't Cover: The Ocular Endpoint Execution Gap
Discover how specialized endpoint execution closes critical gaps in ophthalmic trials, improving assessment consistency, protocol adherence, data quality, and participant retention.
-
Recruiting & Retaining More Patients Per Site:
Through Home Trial Support (HTS) services, MRN is able to enhance the accessibility of clinical trials while reducing the emotional toll on their patients suffering from loss of mobility.
-
The Neural Crystal Ball: Forecasting Future CNS Drug Development4/15/2026
Advances in the industry are redefining how we treat neurological and psychiatric disorders. In this presentation, Dr. Beatrice Setnik examines the trends and innovations shaping the next generation of therapies.
-
Ophthalmology Assessments Made Simple: A Guide For Clinical Trials1/29/2025
Explore the importance and requirements of ophthalmology assessments as well as the key challenges that complicate their implementation at clinical sites.
-
Taking A Statistics-Driven Approach To Clinical Trial Planning3/12/2025
Clinical trials are inherently complex, and even well-structured studies may struggle to achieve statistical significance due to challenges in study design, patient selection, and data variability.
-
Early Detection vs. Overdiagnosis: The ctDNA Screening Paradox6/4/2026
Discover how ctDNA could transform early cancer detection and why the BRCA model offers important lessons for balancing innovation, risk, and meaningful patient outcomes.
-
Overcoming Challenges In Obesity Trials2/12/2026
Obesity trials face high dropout rates due to long durations and complex requirements. Overcome these hurdles with personalized engagement, expert lifestyle support, and proactive patient care.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Reach critical first-in-human milestones faster with experienced teams, rapid study start-up, and real-time data that reduce complexity, inform decisions, and de-risk development.
-
Bispecific ADCs are reshaping cancer care. Early-phase development is critical, requiring agile CRO support, scientific depth, and real-time data to guide biotech sponsors toward long-term success.
-
Discover ways to amplify dialogue, trust, and participation around your clinical trials with Citeline’s end-to-end enterprise patient engagement and recruitment solution.
-
Learn how clinical supply organizations can reduce manual effort, strengthen compliance, improve global coordination, and maintain control across evolving clinical trial supply chains.
-
CSSi offers unmatched depth and breadth in therapeutic expertise, providing full-spectrum, in-house capabilities, positing the organization as a true end-to-end partner in clinical trials.